65 Einträge | 1, 2, 3, 4 › » |
Seite 1 / 4
![]() |
The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation. |
Unger C, Kiss I, Vasas A, Lajter I, Kramer N, Atanasov AG, Nguyen CH, Chatuphonprasert W, Brenner S, Krieger S, McKinnon R, Peschel A, Kain R, Saiko P, Szekeres T, Kenner L, Hassler MR, Diaz R, Frisch R, Dirsch VM, Jäger W, de Martin R, Bochkov VN, Passreiter CM, Peter-Vörösmarty B, Mader RM, Grusch M, Dolznig H, Kopp B, Zupko I, Hohmann J, Krupitza G |
Phytomedicine : international journal of phytotherapy and phytopharmacology. 2015 Jun 26. pii: S0944-7113(15)00182-8. doi: 10.1016/j.phymed.2015.06.003 |
PMID: 26220634 |
STAT3 regulated ARF expression suppresses prostate cancer metastasis. |
Pencik J, Schlederer M, Gruber W, Unger C, Walker SM, Chalaris A, Marié IJ, Hassler MR, Javaheri T, Aksoy O, Blayney JK, Prutsch N, Skucha A, Herac M, Krämer OH, Mazal P, Grebien F, Egger G, Poli V, Mikulits W, Eferl R, Esterbauer H, Kennedy R, Fend F, Scharpf M, Braun M, Perner S, Levy DE, Malcolm T, Turner SD, Haitel A, Susani M, Moazzami A, Rose-John S, Aberger F, Merkel O, Moriggl R, Culig Z, Dolznig H, Kenner L |
Nature communications. 2015 Jul 22. pii: ncomms8736. doi: 10.1038/ncomms8736 |
PMID: 26198641 |
Response to imatinib as a function of target kinase expression in recurrent glioblastoma. |
Hassler MR, Vedadinejad M, Flechl B, Haberler C, Preusser M, Hainfellner JA, Wöhrer A, Dieckmann KU, Rössler K, Kast R, Marosi C |
SpringerPlus. 2014 Feb 25. doi: 10.1186/2193-1801-3-111. pii: 1455. pmc: PMC4320134 |
PMID: 25674429 |
Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasation. |
Kiss I, Unger C, Huu CN, Atanasov AG, Kramer N, Chatruphonprasert W, Brenner S, McKinnon R, Peschel A, Vasas A, Lajter I, Kain R, Saiko P, Szekeres T, Kenner L, Hassler MR, Diaz R, Frisch R, Dirsch VM, Jäger W, de Martin R, Bochkov VN, Passreiter CM, Peter-Vörösmarty B, Mader RM, Grusch M, Dolznig H, Kopp B, Zupko I, Hohmann J, Krupitza G |
Cancer letters. 2014 Nov 15. pii: S0304-3835(14)00675-2. doi: 10.1016/j.canlet.2014.11.019 |
PMID: 25444930 |
Sorafenib for patients with pretreated recurrent or progressive high-grade glioma: a retrospective, single-institution study. |
Hassler MR, Ackerl M, Flechl B, Sax C, Wöhrer A, Widhalm G, Dieckmann K, Hainfellner J, Preusser M, Marosi C |
Anti-cancer drugs. 2014 May 26. doi: 10.1097/CAD.0000000000000077 |
PMID: 24441743 |
Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study. |
Hassler MR, Pfeifer W, Knocke-Abulesz TH, Geissler K, Altorjai G, Dieckmann K, Marosi C |
Wiener klinische Wochenschrift. 2013 Aug 2. doi: 10.1007/s00508-013-0402-7 |
PMID: 23907204 |
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma. |
Hassler MR, Schiefer AI, Egger G |
Epigenomics. 2013 Jul 30. doi: 10.2217/epi.13.39 |
PMID: 23895653 |
The dichloromethane extract of the ethnomedicinal plant Neurolaena lobata inhibits NPM/ALK expression which is causal for anaplastic large cell lymphomagenesis. |
Unger C, Popescu R, Giessrigl B, Laimer D, Heider S, Seelinger M, Diaz R, Wallnöfer B, Egger G, Hassler M, Knöfler M, Saleh L, Sahin E, Grusch M, Fritzer-Szekeres M, Dolznig H, Frisch R, Kenner L, Kopp B, Krupitza G |
International journal of oncology. 2012 Nov 6. doi: 10.3892/ijo.2012.1690 |
PMID: 23135783 |
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. |
Laimer D, Dolznig H, Kollmann K, Vesely PW, Schlederer M, Merkel O, Schiefer AI, Hassler MR, Heider S, Amenitsch L, Thallinger C, Staber PB, Simonitsch-Klupp I, Artaker M, Lagger S, Turner SD, Pileri S, Piccaluga PP, Valent P, Messana K, Landra I, Weichhart T, Knapp S, Shehata M, Todaro M, Sexl V, Höfler G, Piva R, Medico E, Ruggeri BA, Cheng M, Eferl R, Egger G, Penninger JM, Jaeger U, Moriggl R, Inghirami G, Kenner L |
Nature medicine. 2012 Oct 14. pii: nm.2966. doi: 10.1038/nm.2966 |
PMID: 23064464 |
Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma. |
Hassler MR, Klisaroska A, Kollmann K, Steiner I, Bilban M, Schiefer AI, Sexl V, Egger G |
Biochimie. 2012 Jun 9. pii: S0300-9084(12)00232-5. doi: 10.1016/j.biochi.2012.05.029. pmc: PMC3480637 |
PMID: 22687603 |
Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysis. |
Horak P, Wöhrer A, Hassler M, Hainfellner J, Preusser M, Marosi C |
Journal of neuro-oncology. 2012 May 20. doi: 10.1007/s11060-012-0896-2 |
PMID: 22610940 |
Epigenomics of cancer - emerging new concepts. |
Hassler MR, Egger G |
Biochimie. 2012 May 17. pii: S0300-9084(12)00192-7. doi: 10.1016/j.biochi.2012.05.007. pmc: PMC3480634 |
PMID: 22609632 |
Attitudes towards palliative care in primary metastatic cancer: a survey among oncologists. |
Kierner KA, Gartner V, Bartsch R, Hladschik-Kermer B, Gruber A, Hassler M, Watzke HH |
Wiener klinische Wochenschrift. 2010 Feb 23. doi: 10.1007/s00508-009-1295-3 |
PMID: 20177859 |
Improvement of a dendritic cell-based tumour vaccine by an influenza virus. |
Sachet M, Friedl J, Hassler M, Ploder M, Stary G, Stift A, Bergmann M |
European journal of clinical investigation. 2009 Oct 6. pii: ECI2210. doi: 10.1111/j.1365-2362.2009.02210.x |
PMID: 19807781 |
Neurocognitive training in patients with high-grade glioma: a pilot study. |
Hassler MR, Elandt K, Preusser M, Lehrner J, Binder P, Dieckmann K, Rottenfusser A, Marosi C |
Journal of neuro-oncology. 2009 Sep 10. doi: 10.1007/s11060-009-0006-2 |
PMID: 19763790 |
Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma. |
Bachleitner-Hofmann T, Friedl J, Hassler M, Hayden H, Dubsky P, Sachet M, Rieder E, Pfragner R, Brostjan C, Riss S, Niederle B, Gnant M, Stift A |
Oncology reports. 2009 May 8. |
PMID: 19424640 |
Meningioma. |
Marosi C, Hassler M, Roessler K, Reni M, Sant M, Mazza E, Vecht C |
Critical reviews in oncology/hematology. 2008 Mar 14. pii: S1040-8428(08)00022-X. doi: 10.1016/j.critrevonc.2008.01.010 |
PMID: 18342535 |
Allogeneic tumor lysate can serve as both antigen source and protein supplementation for dendritic cell culture. |
Dubsky P, Hayden H, Sachet M, Bachleitner-Hofmann T, Hassler M, Pfragner R, Gnant M, Stift A, Friedl J |
Cancer immunology, immunotherapy : CII. 2007 Nov 21. doi: 10.1007/s00262-007-0422-0 |
PMID: 18030468 |
Venous thromboembolism and survival in patients with high-grade glioma. |
Simanek R, Vormittag R, Hassler M, Roessler K, Schwarz M, Zielinski C, Pabinger I, Marosi C |
Neuro-oncology. 2007 Feb 27. pii: 15228517-2006-035. doi: 10.1215/15228517-2006-035. pmc: PMC1871666 |
PMID: 17327573 |
Diversity of cytogenetic and pathohistologic profiles in glioblastoma. |
Hassler M, Seidl S, Fazeny-Doerner B, Preusser M, Hainfellner J, Rössler K, Prayer D, Marosi C |
Cancer genetics and cytogenetics. 2006 Apr 17. pii: S0165-4608(05)00502-9. doi: 10.1016/j.cancergencyto.2005.08.021 |
PMID: 16616111 |
65 Einträge | 1, 2, 3, 4 › » |
Seite 1 / 4
![]() |